Fabp3 as a biomarker of skeletal muscle toxicity in the rat: Comparison with conventional biomarkers

Toxicological Sciences

Volumn 103, Issue 2, 2008, Pages 382-396

  Pritt, Michael I ^a   Hall, David Greg ^a   Recknor, Justin ^a   Credille, Kelly M ^a   Brown, Donna D ^a   Yumibe, Nathan P ^a   Schultze, Albert Eric ^a   Watson, David E ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Biomarker; Necrosis; Predictivity; Rat; Skeletal muscle; Tissue distribution

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CREATINE KINASE MM; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL TYPE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC VALUE; EDEMA; FEMALE; HISTOPATHOLOGY; HYALINE DEGENERATION; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MUSCLE CELL; MUSCLE INJURY; MUSCLE NECROSIS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; RAT; SENSITIVITY AND SPECIFICITY; SKELETAL MUSCLE; SOLEUS MUSCLE; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION; TISSUE LEVEL; TISSUE SPECIFICITY;

ANIMALS; ANTIBODIES, BLOCKING; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; FATTY ACID-BINDING PROTEINS; FEMALE; MALE; MUSCLE FIBERS; MUSCLE, SKELETAL; MYOCARDIUM; MYOSITIS; PREDICTIVE VALUE OF TESTS; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; XENOBIOTICS;

RATTUS;

EID: 43349091319     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfn042     Document Type: Article

References (34)

1. Armstrong, R., and Phelps, R. (1984). Muscle fiber type composition of the rat hindlimb. Am. J. Anat. 171, 259-272.
2. Bender, H. S. (2003). Muscle. In Veterinary Laboratory Medicine: Clinical Pathology (K. S. Latimer, E. A. Mahaffey, and K. W. Prasse, Eds.), 4th ed., pp. 260-269. Iowa State University Press, Ames, IA.
3. Brooks, D. A., Etgen, G. J., Rito, C. J., Shuker, A. J., Dominianni, S. J., Warshawsky, A. M., Ardecky, R., Paterniti, J. R., Tyhonas, J., Karanewski D. S., et al. (2001). Design and synthesis of 2-methyl-2-{4-[2-(5-methyl-2-aryloxazol-4-yl)ethoxy]phenoxy}propionic acids: A new class of dual PPARα/γ agonists. J. Med. Chem. 44 2061-2064.
4. Celio, M. R., and Heizmann, C. W. (1982). Calcium-binding protein parvalbumin is associated with fast contracting muscle fibers. Nature 297, 504-506.
5. Charatan, F. (2001). Bayer decides to withdraw cholesterol lowering drug. BMJ 323, 359.
6. Crisman, T., Claffey, K., Saouaf, R., Hanspal, J., and Brecher, P. (1987). Measurement of rat heart fatty acid binding protein by Elisa. Tissue distribution, developmental changes and subcellular distribution. J. Mol. Cell. Cardiol. 19, 423-431.
7. Dare, T. O., Davies, H. A., Turton, J. A., Lomas, L., Williams, T. C., and York, M. J. (2002). Application of surface-enhanced laser desorption/ ionization technology to the detection and identification of urinary parvalbumin-α: A biomarker of compound-induced skeletal muscle toxicity in the rat. Electrophoresis 23, 3241-3251.
8. DeSouza, A., Cornwell, P., Dai, X., Caguyong, J., and Ulrich, R. (2006). Agonists of the peroxisome proliferator-activated receptor alpha induce a fiber-type-selective transcriptional response in rat skeletal muscle. Toxicol. Sci. 92, 578-586.
9. Glatz, J., Schaap, F., Binas, B., Van der Vusse, G., and Luiken, J. (2003). Cytoplasmic fatty acid-binding protein facilitates fatty acid utilization by skeletal muscle. Acta Physiol. Scand. 178, 367-371.
10. Graham, D., Staffa, J., Shatin, D., Andrade, S., Schech, S., Grenade, L., Girwitz, J., Chan, K., Goodman, M., and Platt, R. (2004). Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA 292, 2585-2590.
11. Hodel, C. (2002). Myopathy and rhabdomyolysis with lipid-lowering drugs. Toxicol. Lett. 128, 159-168.
12. Hoffmann, W. E., Wilson, B. W., and Solter, P. F. (1999). Clinical enzymology. In The Clinical Chemistry of Laboratory Animals (W. F. Loeb and F. W. Quimby, Eds.), 2nd ed., pp. 399-454. Taylor and Francis, Philadelphia.
13. Horwitz, J., Bullard, B., and Mercola, D. (1979). Interaction of troponin subunits. J. Biol. Chem. 254(2), 350-355.
14. Katrukha, A., Bereznikova, A., Esakova, T., Pettersson, K., Lovgren, T., Severina, M., Pulkki, K., Vuopio-Pulkki, L., and Gusev, N. (1997). Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex. Clin. Chem. 43 (8), 1379-1385.
15. Kimura, H., Odani, S., Nishi, S., Sato, H., Arakawa, M., and Ono, T. (1991). Primary structure and cellular distribution of two fatty acid-binding proteins in adult rat kidneys. J. Biol. Chem. 266 (9), 5963-5972.
16. Koerker, D., Sweet, I., and Baskin, D. (1990). Insulin binding to individual rat skeletal muscles. Am. J. Physiol. 259, 517-523.
17. Lumeij, J. T. (1997). Avian clinical biochemistry. In Clinical Biochemistry of Domestic Animals (J. J. Kaneko, J. W. Harvey, and M. L. Bruss, Eds.), 5th ed., pp. 857-883. Academic Press, San Diego.
18. Maatman, R., Van de Westerlo, E., Van Kuppevelt, T., and Veerkamp, J. (1992). Molecular identification of the liver- and the heart-type fatty acid-binding proteins in the human and rat kidney. Biochem. J. 288, 285-290.
19. McNeil, P., and Ito, S. (1990). Molecular traffic through plasma membrane disruptions of cells in vivo. J. Cell. Sci. 96, 549-556.
20. McNeil, P., and Khakee, R. (1992). Disruptions of muscle fiber plasma membranes. Am. J. Pathol. 140, 1097-1109.
21. Panteghini, M., Bais, R., and van Solinge, W. (2006). Enzymes. In Tietz Textbook of Clinical Chemistry and Molecular Diagnostics (C. A. Burtis, E. R. Ashwood, and D. E. Bruns, Eds.), 4th ed., pp. 597-643. Elsevier Saunders, St Louis, MO.
22. Pelsers, M., Hermens, W., and Glatz, J. (2005). Fatty acid-binding proteins as plasma markers of tissue injury. Clin. Chim. Acta 352, 15-35.
23. Rosenson, R. S. (2004). Current overview of statin-induced myopathy. Am. J. Med. 116, 408-416.
24. SAS Institute, Inc. (2004). SAS/STAT 9.1 User's Guide. SAS Institute, Inc, Cary, NC.
25. Sayers, S., and Clarkson, P. (2003). Short-term immobilization after eccentric exercise. Part II: Creatine kinase and myoglobin. Med. Sci. Sports Exerc. 35, 762-768.
26. Simpson, J., Labugger, R., Collier, C., Brison, R., Iscoe, S., and Van Eyk, J. (2005). Fast and slow skeletal troponin I in serum from patients with various skeletal muscle disorders: A pilot study. Clin. Chem. 51:(6), 966-972.
27. Smith, P., Eydelloth, R., Grossman, S., Stubbs, R., Schwartz, M., Germershausen, J., Vyas, K., Kari, P., and MacDonald, J. (1991). HMG-CoA reductase inhibitor-induced myopathy in the rat: Cyclosporin a interaction and mechanism studies. J. Pharmacol. Exp. Ther. 257 1225-1235.
28. Sorichter, S., Mair J., Koller, A.; Pelsers, M., Puschendorf, B., and Glatz, J. (1998). Early amessment of exercise induced skeletal muscle injury using plasma fatty acid binding protein. Br. J. sports Med. 32, 121-124.
29. Sorichter, S., Puschendorf, B, and Mair, J. (1999), Skeletal muscle injury induced by eccentric muscle action: Muscle proteins as markers of muscle fiber injury. Exerc. Immunol. Rev. 5, 5-21.
30. Storch, J., and Thumser, A. (2000). The Fatty acid transport function of fatty-acid-binding proteins. Biochim. Biophys. Acta 1486, 28-44.
31. Van Nieuwenhoven, F., Kliene, A., Wodzig, K., Hermens, W., Kragten, H., Maussen, J., Punt, C., Van Dieijen, M., Van Der Cusse, G., and Glatz, J. (1995). Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. Circulation 92, 2848-2854.
32. Vork, M., Glatz, I., Surtel, D., Knubben, J., and Van der Vusse, G. (1991). A sandwich enzyme linked immuno-sorbent assay for the determination of rat heart fatty acid-binding protein using the streptavidin-biotin system. Application to tissue and effluent samples from normoxic rat heart perfusion. Biochim. Biophys. Acta 1075 199-205.
33. Westwood, R., Bigley, A., Randall, K., Marsden, A., and Scott, R. (2005). Statin-induced muscle necrosis in the rat: Distribution, development, and fibre selectivity. Toxicol. Pathol. 33, 246-257.
34. Zhen, E., Berna, M., Zhaoyan, J., Pritt, M., Watson, D., Ackermann, B., and Hale, J. (2007). Quantification of heart fatty acid binding protein as a biomarker for drug-induced cardiac and musculoskeletal necroses. Proteomics Clin. Appl. 1, 661-671.